FANCA anticorps (AA 1272-1439)

N° du produit ABIN7870404

L’anticorps anti-FANCA Polyclonal Lapin est utilisé pour la détection de FANCA dans des échantillons de Rat et Souris. Il a été validé pour WB, ELISA et FACS.

Aperçu rapide pour FANCA anticorps (AA 1272-1439) (ABIN7870404)

Antigène: FANCA (Fanconi Anemia Group A Protein (FANCA))

Reactivité: Rat, Souris

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp FANCA est non-conjugé

Application: Western Blotting (WB), ELISA, Flow Cytometry (FACS)

Détail du produit anti-FANCA anticorps

Épitope: AA 1272-1439

Fonction: Fanca Antibody / Fanconi anemia group A protein / FAA

Purification: Antigen affinity purified

Immunogène: Recombinant mouse protein (amino acids E1272-F1439) was used as the immunogen for the Fanca antibody.

Isotype: IgG

Information d'application

Indications d'application: Optimal dilution of the Fanca antibody should be determined by the researcher.

Restrictions: For Research Use only

Stockage

Format: Lyophilized

Buffer: 0.5 mg/mL if reconstituted with 0.2 mL sterile DI water

Stock: 4 °C,-20 °C

Stockage commentaire: After reconstitution, the Fanca antibody can be stored for up to one month at 4oC. For long-term, aliquot and store at -20oC. Avoid repeated freezing and thawing.

Détails sur FANCA

Antigène: FANCA (Fanconi Anemia Group A Protein (FANCA))

Autre désignation: Fanca

Sujet: Fanconi anaemia, complementation group A, also known as FAA, FACA and FANCA, is a protein which in humans is encoded by the FANCA gene. Acts upstream of or within several processes, including gonad development, regulation of CD40 signaling pathway, and regulation of regulatory T cell differentiation. Predicted to be located in nucleoplasm. Predicted to be part of Fanconi anaemia nuclear complex. Is expressed in several structures, including gut, liver, lung, reproductive system, and spleen. Used to study Fanconi anemia complementation group A. Human ortholog(s) of this gene implicated in several diseases, including Fanconi anemia (multiple), acute myeloid leukemia, esophagus squamous cell carcinoma, ovarian disease (multiple), and skin melanoma. Orthologous to human FANCA (FA complementation group A).

UniProt: Q9JL70

Pathways: Réparation de l'ADN